Cambridge Cognition Holdings Plc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.089x

Cambridge Cognition Holdings Plc cash flow conversion efficiency. Based on the latest financial reports, Cambridge Cognition Holdings Plc (COG) has a cash flow conversion efficiency ratio of 0.089x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX196.00K ≈ $23.85 USD) by net assets (GBX2.19 Million ≈ $266.46 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Cambridge Cognition Holdings Plc (2010–2025)

Cash flow conversion efficiency of Cambridge Cognition Holdings Plc from 2010 to 2025. This chart illustrates how Cambridge Cognition Holdings Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Cambridge Cognition Holdings Plc stock price today for real-time trading data and today's change.

Cambridge Cognition Holdings Plc Cash Flow Conversion Ratio Explained

Cambridge Cognition Holdings Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Cambridge Cognition Holdings Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cambridge Cognition Holdings Plc ranked by their cash flow conversion efficiency. Also see market cap of Cambridge Cognition Holdings Plc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Seoul Food Ind Co Ltd
KO:004415
-0.015x
Trustco Group Holdings
JSE:TTO
-0.004x
Northern Bear Plc
LSE:NTBR
0.123x
ICG Longbow Senior Secured UK Property Debt Investments Ltd
LSE:LBOW
0.032x
Orchard Funding Group PLC
LSE:ORCH
-0.043x
Sable Exploration and Mining Ltd
JSE:SXM
N/A
Mineral & Financial Investments Ltd
LSE:MAFL
0.012x
Reco International Group Inc
V:RGI
0.037x

Annual Cash Flow Conversion Efficiency for Cambridge Cognition Holdings Plc (2010–2025)

The table below shows the annual cash flow conversion efficiency of Cambridge Cognition Holdings Plc from 2010 to 2025. Review cash generation quality of Cambridge Cognition Holdings Plc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX2.99 Million
≈ $364.28
GBX-232.00K
≈ $-28.23
-0.077x +91.56%
2024-12-31 GBX3.36 Million
≈ $409.06
GBX-3.08 Million
≈ $-375.36
-0.918x +76.30%
2023-12-31 GBX1.28 Million
≈ $156.10
GBX-4.97 Million
≈ $-604.34
-3.871x -121.93%
2022-12-31 GBX95.00K
≈ $11.56
GBX1.68 Million
≈ $204.04
17.653x +183.59%
2021-12-31 GBX632.00K
≈ $76.90
GBX3.93 Million
≈ $478.65
6.225x -65.01%
2020-12-31 GBX57.00K
≈ $6.94
GBX1.01 Million
≈ $123.37
17.789x +625.41%
2019-12-31 GBX-944.00K
≈ $-114.86
GBX-2.31 Million
≈ $-281.67
2.452x +100.30%
2018-12-31 GBX-526.00K
≈ $-64.00
GBX-644.00K
≈ $-78.36
1.224x +694.70%
2017-12-31 GBX3.03 Million
≈ $368.79
GBX-624.00K
≈ $-75.92
-0.206x -224.52%
2016-12-31 GBX2.86 Million
≈ $348.10
GBX473.00K
≈ $57.55
0.165x +133.00%
2015-12-31 GBX1.41 Million
≈ $171.92
GBX-708.00K
≈ $-86.14
-0.501x -48.15%
2014-12-31 GBX2.05 Million
≈ $249.30
GBX-693.00K
≈ $-84.32
-0.338x +70.86%
2013-12-31 GBX2.13 Million
≈ $259.16
GBX-2.47 Million
≈ $-300.77
-1.161x -378.81%
2012-12-31 GBX-1.68 Million
≈ $-204.82
GBX-700.75K
≈ $-85.26
0.416x +129.22%
2011-12-31 GBX-375.68K
≈ $-45.71
GBX535.21K
≈ $65.12
-1.425x +37.78%
2010-12-31 GBX-240.29K
≈ $-29.24
GBX550.16K
≈ $66.94
-2.290x --

About Cambridge Cognition Holdings Plc

LSE:COG UK Health Information Services
Market Cap
$180.62K
GBX1.48 Billion GBX
Market Cap Rank
#31382 Global
#1033 in UK
Share Price
GBX27.50
Change (1 day)
-1.79%
52-Week Range
GBX27.00 - GBX43.50
All Time High
GBX192.50
About

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric d… Read more